Plasma Fractionation Product Market Report – 2025 Outlook, Trends, Share, Size & Forecast

MarkNtel Advisors has unveiled its latest research report on the Plasma Fractionation Market, providing an in-depth analysis of market dynamics, growth prospects, and competitive landscape. This report serves as a valuable resource for stakeholders aiming to capitalize on emerging opportunities and navigate potential challenges in the Plasma Fractionation industry.

Plasma Fractionation Market Size: 2025 Outlook

The Global Plasma Fractionation Market size was valued at around USD 31.18 billion in 2024 and is projected to reach USD 42.39 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.51% during the forecast period, i.e., 2025-30. The demand for plasma-derived therapy has been increasing worldwide, owing to the prevalence of rare disorders in the global population. In 2023, according to the Rare Disease Day Organization, around 300 million people worldwide are living with a rare disorder.

U.S. tariffs are changing—are you prepared? Download your free sample PDF of the report for timely data and expert advice – https://www.marknteladvisors.com/query/request-sample/plasma-fractionation-market.html

📘 Scope of the Report

• Forecasts till 2030 with year-wise market breakdown
• Geographical and segment-level analysis
• Company profiles and strategic insights
• Key market drivers and restraints
• Analysis of market trends and investment opportunities

What’s Driving the Market?

Escalating Geriatric Population Driving the Demand for Plasma-derived Therapies – Globally, the surging geriatric population has resulted in a substantial boost in the incidences of diseases like immunodeficiency, neurological disorders, etc., which require plasma-derived therapies for treatment. The increment in the geriatric population has been attributed to the increasing life expectancy of the elderly population in various countries like China, Japan, etc., as a result of their improved healthcare infrastructure. Consequently, as the number of geriatric patients has been increasing, there has been an enhanced demand for plasma-derived therapeutic products, presenting a strong market situation for plasma fractionation manufacturers, particularly immunoglobulins and coagulation factors during historical years.

Access Full Market Insights & Key Statistics!

Use your official business email to connect with our team and enjoy full access with priority support.

Plasma Fractionation Market Segmentation

By Product

• Immunoglobulin- Market Size & Forecast 2020-2030, (USD Million)
• Coagulation Factors- Market Size & Forecast 2020-2030, (USD Million)
• Albumin- Market Size & Forecast 2020-2030, (USD Million)
• Protease Inhibitor- Market Size & Forecast 2020-2030, (USD Million)
• Others (Plasminogen, Antithrombin III, etc.) - Market Size & Forecast 2020-2030, (USD Million)

By Application

• Neurology- Market Size & Forecast 2020-2030, (USD Million)
• Immunology- Market Size & Forecast 2020-2030, (USD Million)
• Hematology- Market Size & Forecast 2020-2030, (USD Million)
• Critical Care- Market Size & Forecast 2020-2030, (USD Million)
• Pulmonology- Market Size & Forecast 2020-2030, (USD Million)
• Rheumatology- Market Size & Forecast 2020-2030, (USD Million)
• Others (Oncology, Pediatrics, etc.) - Market Size & Forecast 2020-2030, (USD Million)

By End User

• Hospitals - Market Size & Forecast 2020-2030, (USD Million)
• Specialty Clinics- Market Size & Forecast 2020-2030, (USD Million)
• Research Facilities - Market Size & Forecast 2020-2030, (USD Million)

By Region

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

🏢 Industry Leaders: Who’s Dominating the Plasma Fractionation Market?

The market is highly competitive, with players launching innovation-driven products and investing in strategic partnerships. Key participants include:

• Biotest A.G.
• Octapharma A.G.
• Adma Biologics
• Aegros
• CSL Limited
• Grifols S.A.
• Kedrion Biopharma Inc.
• Bio Products Laboratory Ltd                                  
• Takeda Pharmaceuticals
• Emergent Bio solutions
• Intas Pharmaceutical
• Plasma Gen Biosciences
• S K Plasma
• Australian Red Cross Lifeblood

These companies are focused on health-based R&D, expansion, and functional ingredient diversification.

Looking for Global, Regional or country-specific reports on this market?

Visit our website or simply fill out the inquiry form, and our team will reach out with customized insights and support -  https://www.marknteladvisors.com/query/request-customization/plasma-fractionation-market.html

🧠 Frequently Asked Questions (FAQs)

1. What are the main drivers of the Plasma Fractionation market?
2. Which segment leads the Plasma Fractionation industry?
3. What regulatory challenges impact product development?
4. Who are the top players in the Plasma Fractionation industry?

About US:

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us:

MarkNtel Advisors LLP

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511 

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

For Sales Enquiries: [email protected]